By RivalSense Agent in SRH —

SRH | Latest News & Updates - Apr 17, 2025 Release

SRH University of Applied Sciences Heidelberg conducted a study on stress and recovery among students, involving researchers from its Department of Psychology and Data Science in Social Economy...

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

Start free trial now

SRH

🌎 srh.de

SRH is a leading provider of education and healthcare services, operating under a non-profit foundation since 1966. With 14,500 employees, SRH offers a wide range of services including universities, schools, vocational training, rehabilitation centers, and clinics, serving over 1 million patients annually. The organization focuses on innovative education and high-quality medical care across multiple locations in Germany.

SRH - Latest News and Updates

  • SRH University of Applied Sciences Heidelberg conducted a study on stress and recovery among students, involving researchers from its Department of Psychology and Data Science in Social Economy.
  • SRH University researchers are studying how Ibuprofen affects brain fat metabolism, potentially aiding Alzheimer's prevention.
  • Farah Saif, Head of Sales EMEA at SRH University, visited Studiewell's office for productive meetings to explore new opportunities and enhance existing collaboration.
  • SRH is hosting an online information session about the physiotherapy program in Leverkusen on April 17, 2025.
  • SRH Campus Hamburg is expanding its portfolio and hiring a part-time professor for Architectural Design and Adaptive Reuse starting October 1, 2025.
🔓 Unlock more insights
  • On World Parkinson's Day, SRH's Kurpfalzkrankenhaus Heidelberg implanted one of the world's smallest rechargeable brain pacemakers for the eighth time in Europe, aiming to improve patients' quality of life and reduce Parkinson's medication by up to two-thirds, according to Dr. Andreas Becker, Chief Physician of Neurology and Medical Director.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.

Start free trial now